The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Biohaven Ltd (NYSE: BHVN) closed the day trading at $9.62 down -3.12% from the previous closing price of $9.93. In other words, the price has decreased by -$3.12 from its previous closing price. On the day, 3.18 million shares were traded. BHVN stock price reached its highest trading level at $10.015 during the session, while it also had its lowest trading level at $9.32.
Ratios:
For a better understanding of BHVN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 2.86.
On November 26, 2025, UBS Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $11.
Bernstein Downgraded its Outperform to Mkt Perform on November 06, 2025, while the target price for the stock was maintained at $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 17 ’25 when Clark George C. bought 17,000 shares for $8.52 per share. The transaction valued at 144,770 led to the insider holds 20,000 shares of the business.
Bailey Gregory bought 400,000 shares of BHVN for $3,000,000 on Nov 13 ’25. The Director now owns 2,020,071 shares after completing the transaction at $7.50 per share. On Nov 13 ’25, another insider, CHILDS JOHN W, who serves as the Director of the company, bought 3,333,333 shares for $7.50 each. As a result, the insider paid 24,999,998 and bolstered with 5,653,904 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1276463232 and an Enterprise Value of 1072285568.
Stock Price History:
The Beta on a monthly basis for BHVN is 3.56, which has changed by -0.74648964 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $44.28, while it has fallen to a 52-week low of $7.48. The 50-Day Moving Average of the stock is -12.24%, while the 200-Day Moving Average is calculated to be -37.09%.
Shares Statistics:
Over the past 3-months, BHVN traded about 3.93M shares per day on average, while over the past 10 days, BHVN traded about 3449060 shares per day. A total of 132.69M shares are outstanding, with a floating share count of 111.06M. Insiders hold about 16.30% of the company’s shares, while institutions hold 65.40% stake in the company. Shares short for BHVN as of 1765756800 were 17004534 with a Short Ratio of 4.32, compared to 1763078400 on 13125722. Therefore, it implies a Short% of Shares Outstanding of 17004534 and a Short% of Float of 14.060001.
Earnings Estimates
. The current market rating for Biohaven Ltd (BHVN) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.96, with high estimates of -$0.34 and low estimates of -$1.7.
Analysts are recommending an EPS of between -$5.1 and -$5.88 for the fiscal current year, implying an average EPS of -$5.52. EPS for the following year is -$2.88, with 6.0 analysts recommending between -$1.35 and -$6.37.
